Literature DB >> 10479161

Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression.

Q Mohamed-Ali1, N E Elwali, A A Abdelhameed, A Mergani, S Rahoud, K E Elagib, O K Saeed, L Abel, M M Magzoub, A J Dessein.   

Abstract

Lethal disease in Schistosoma mansoni infections is mostly due to portal hypertension caused by hepatic periportal fibrosis. To evaluate the factors that may determine severe disease, livers and spleens were examined by ultrasound in a Sudanese population living in a village where S. mansoni is endemic. Early (FI), moderate (FII), or advanced (FIII) fibrosis was observed in 58%, 9%, and 3% of the population, respectively. Although FI affected 50%-70% of the children and adolescents, FII prevalence was low in subjects </=20 years old but increased sharply (45%-58%) in men 21-30 years old and was associated with the highest infections. Portal and splenic vein diameters were increased in one-third of persons with FII and in almost all with FIII disease. Severe disease, FII or FIII with portal hypertension, affected 6% of the population, was associated with splenomegaly, occurred mostly in adult men, and was clustered in a few pedigrees. These observations suggest that infection intensity and duration, gender-related factors, and inherited factors are important in fibrosis development.

Entities:  

Mesh:

Year:  1999        PMID: 10479161     DOI: 10.1086/314999

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens.

Authors:  Sarah Joseph; Frances M Jones; Gachuhi Kimani; Joseph K Mwatha; Timothy Kamau; Francis Kazibwe; Jovanice Kemijumbi; Narcis B Kabatereine; Mark Booth; Henry C Kariuki; John H Ouma; Birgitte J Vennervald; David W Dunne
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 2.  Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective.

Authors:  Brian B Graham; Angela Pontes Bandeira; Nicholas W Morrell; Ghazwan Butrous; Rubin M Tuder
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

Review 3.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.

Authors:  Ghada Boghdadi; Dalia Abdel Khalik; Sami Abdel Wahab; Adel Farghaly
Journal:  Parasitol Res       Date:  2012-09-20       Impact factor: 2.289

5.  The burden, pattern and factors that contribute to periportal fibrosis in HIV-infected patients in an S. mansoni endemic rural Uganda.

Authors:  Ponsiano Ocama; Kenneth Christopher Opio; Emmanuel Seremba; Paul Ajal; Betty Stephanie Apica; Emmanuel Odongo Aginya
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

6.  Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.

Authors:  L F Alves Oliveira; E C Moreno; G Gazzinelli; O A Martins-Filho; A M S Silveira; A Gazzinelli; L C C Malaquias; P LoVerde; P Martins Leite; R Correa-Oliveira
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection.

Authors:  Shona Wilson; Frances M Jones; Joseph K Mwatha; Gachuhi Kimani; Mark Booth; H Curtis Kariuki; Birgitte J Vennervald; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

8.  No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection.

Authors:  Carole Eboumbou Moukoko; Nasureldin El Wali; O K Saeed; Qurashi Mohamed-Ali; Jean Gaudart; Alain J Dessein; Christophe Chevillard
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Gender-related cytokine patterns in sera of schistosomiasis patients with Symmers' fibrosis.

Authors:  David Nascimento Silva-Teixeira; Cristiane Contigli; José Roberto Lambertucci; José Carlos Serufo; Virmondes Rodrigues
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

10.  Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.

Authors:  P Martins-Leite; G Gazzinelli; L F Alves-Oliveira; A Gazzinelli; L C C Malaquias; R Correa-Oliveira; A Teixeira-Carvalho; A M S Silveira
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.